Novel multifunctional NIR-II aggregation-induced emission nanoparticles-assisted intraoperative identification and elimination of residual tumor
Qu,Qiaojun8,9; Zhang,Zeyu7,8; Guo,Xiaoyong1,6,8; Yang,Junying5; Cao,Caiguang4,8; Li,Changjian7; Zhang,Hui3; Xu,Pengfei2; Hu,Zhenhua4,8; Tian,Jie4,7,8,9
刊名Journal of Nanobiotechnology
2022-03-19
卷号20期号:1页码:15
关键词Aggregation-induced emission NIR-II imaging Phototherapy Phototheranostic Residual tumor
DOI10.1186/s12951-022-01325-9
通讯作者Zhang,Hui(zhang_hui@sxmu.edu.cn) ; Xu,Pengfei(pengfeixuscu@outlook.com) ; Hu,Zhenhua(zhenhua.hu@ia.ac.cn) ; Tian,Jie(jie.tian@ia.ac.cn)
英文摘要AbstractIncomplete tumor resection is the direct cause of the tumor recurrence and metastasis after surgery. Intraoperative accurate detection and elimination of microscopic residual cancer improve surgery outcomes. In this study, a powerful D1–π–A–D2–R type phototheranostic based on aggregation-induced emission (AIE)-active the second near-infrared window (NIR-II) fluorophore is designed and constructed. The prepared theranostic agent, A1 nanoparticles (NPs), simultaneously shows high absolute quantum yield (1.23%), excellent photothermal conversion efficiency (55.3%), high molar absorption coefficient and moderate singlet oxygen generation performance. In vivo experiments indicate that NIR-II fluorescence imaging of A1 NPs precisely detect microscopic residual tumor (2?mm in diameter) in the tumor bed and metastatic lymph nodes. More notably, a novel integrated strategy that achieves complete tumor eradication (no local recurrence and metastasis after surgery) is proposed. In summary, A1 NPs possess superior imaging and treatment performance, and can detect and eliminate residual tumor lesions intraoperatively. This work provides a promising technique for future clinical applications achieving improved surgical outcomes.Graphic Abstract
资助项目National Key Research and Development Program of China[2017YFA0205200] ; National Natural Science Foundation of China (NSFC)[62027901] ; National Natural Science Foundation of China (NSFC)[81930053] ; National Natural Science Foundation of China (NSFC)[92059207] ; National Natural Science Foundation of China (NSFC)[81227901] ; National Natural Science Foundation of China (NSFC)[82102236] ; Beijing Natural Science Foundation[JQ19027] ; Youth Crossover Team Project of the Chinese Academy of Sciences[JCTD-2021-08] ; Strategic Priority Research Program of the Chinese Academy of Sciences[XDA16021200] ; Zhuhai High-level Health Personnel Team Project (Zhuhai)[HLHPTP201703] ; China Postdoctoral Science Foundation[2021M690007] ; the innovative research team of high-level local universities in Shanghai
WOS关键词BREAST-CONSERVING SURGERY ; CANCER ; IRRADIATION ; MARGINS ; ANTIGEN
WOS研究方向Biotechnology & Applied Microbiology ; Science & Technology - Other Topics
语种英语
出版者BioMed Central
WOS记录号BMC:10.1186/S12951-022-01325-9
资助机构National Key Research and Development Program of China ; National Natural Science Foundation of China (NSFC) ; Beijing Natural Science Foundation ; Youth Crossover Team Project of the Chinese Academy of Sciences ; Strategic Priority Research Program of the Chinese Academy of Sciences ; Zhuhai High-level Health Personnel Team Project (Zhuhai) ; China Postdoctoral Science Foundation ; the innovative research team of high-level local universities in Shanghai
内容类型期刊论文
源URL[http://ir.ia.ac.cn/handle/173211/47642]  
专题自动化研究所_中国科学院分子影像重点实验室
通讯作者Zhang,Hui; Xu,Pengfei; Hu,Zhenhua; Tian,Jie
作者单位1.Anhui Medical University
2.Jining Medical University; Institute of Clinical Pharmacy & Pharmacology, Jining First People’s Hospital
3.First Hospital of Shanxi Medical University; Department of Radiology
4.University of Chinese Academy of Sciences; School of Artificial Intelligence
5.Southern Medical University; Department of Hepatobiliary Surgery, Zhujiang Hospital
6.Chinese PLA General Hospital; Department of Gastroenterology, The Third Medical Centre
7.Beihang University; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine and Engineering
8.Chinese Academy of Sciences; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, The State Key Laboratory of Management and Control for Complex Systems, Institute of Automation
9.Shanxi Medical University; College of Medical Imaging
推荐引用方式
GB/T 7714
Qu,Qiaojun,Zhang,Zeyu,Guo,Xiaoyong,et al. Novel multifunctional NIR-II aggregation-induced emission nanoparticles-assisted intraoperative identification and elimination of residual tumor[J]. Journal of Nanobiotechnology,2022,20(1):15.
APA Qu,Qiaojun.,Zhang,Zeyu.,Guo,Xiaoyong.,Yang,Junying.,Cao,Caiguang.,...&Tian,Jie.(2022).Novel multifunctional NIR-II aggregation-induced emission nanoparticles-assisted intraoperative identification and elimination of residual tumor.Journal of Nanobiotechnology,20(1),15.
MLA Qu,Qiaojun,et al."Novel multifunctional NIR-II aggregation-induced emission nanoparticles-assisted intraoperative identification and elimination of residual tumor".Journal of Nanobiotechnology 20.1(2022):15.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace